Journal Papers, Abstracts, and Commentaries
| |
|
Fibrosing Cholestatic Hepatitis Developing within One Month
after Living Donor Liver Transplantation for Chronic Hepatitis C-related
Cirrhosis: A Case Report.
Murakami K, Kawagishi N, Ishida K,
et al
Transplant Proc. 2014
Apr;46(3):995-8..
Abstract
Clinical efficacy of simultaneous splenectomy in liver
transplant recipients with hepatitis C virus.
Morimoto H, Ishiyama K, Ishifuro M,
et al
Transplant Proc. 2014
Apr;46(3):770-3.
Abstract
Optimizing outcome of recurrent hepatitis C virus genotype 4
after living donor liver transplantation: moving forward by looking back.
Dabbous HM, Elmeteini MS, Sakr MA, et al
Transplant Proc. 2014
Apr;46(3):822-7.
Abstract
Expression pattern analysis of hepatocellular carcinoma tumor markers in
viral hepatitis B and C patients undergoing liver transplantation and
resection.
Ha TY, Hwang S, Kim KH,
et al
Transplant Proc. 2014
Apr;46(3):888-93.
Abstract
Association of Genetic Variants With Rapid Fibrosis: Progression After Liver
Transplantation for Hepatitis C.
Layden JE, Tayo BO, Cotler SJ, et
al
Transplantation. 2014
Apr 23
Abstract
Clinical efficacy of simultaneous splenectomy in liver transplant
recipients with hepatitis C virus.
Morimoto H, Ishiyama K, Ishifuro M, et al
Transplant Proc. 2014
Apr;46(3):770-3..
Abstract
Hypertension and hepatitis C virus infection are strong risk
factors for developing late renal dysfunction after living donor liver
transplantation: significance of renal biopsy.
Fujinaga K, Usui M, Yamamoto N, et al
Transplant Proc.
2014 Apr;46(3):804-10.
Abstract
Hepatitis C disease severity in living versus
deceased donor liver transplant recipients: An extended observation study.
Terrault NA, Stravitz RT, Lok AS, et al
Hepatology.
2014 Apr;59(4):1311-9.
Abstract
Liver transplant complications in hepatitis C infected recipients: recurrence
versus rejection.
Gehrau RC, Mas VR, Suh JL, Maluf DG.
Expert Rev Gastroenterol Hepatol.
2014 Mar 18.
Abstract
Management of HCV transplant patients with triple therapy.
Coilly A, Roche B, Duclos-Vallée JC, Samuel D.
Liver
Int. 2014 Feb;34 Suppl
1:46-52.
Abstract
Post-transplant outcomes of patients with and without hepatitis C virus
infection according to donor age and gender matching.
Grąt
M, Kornasiewicz O, Lewandowski Z, et al
Ann
Transplant. 2013 Dec 23;18:705-15.
Abstract
Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver
transplantation for hepatitis C.
Dunn W, O’Neil M, Zhao J, Wu CH, et al
Hepatology. 2013 Oct 1
Abstract
Dynamics of defective hepatitis C virus clones in reinfected liver grafts in
liver transplant recipients; ultra-deep sequencing analysis.
Ohtsuru S, Ueda Y, Marusawa H, Inuzuka T
et al
J Clin Microbiol. 2013 Aug 28.
Abstract
Perioperative blood transfusion affects hepatitis C virus
(HCV)-specific immune responses and outcome following liver transplantation in
HCV-infected patients.
Subramanian V, Bharat A, Vachharajani
N, et al.
HPB (Oxford). 2013 Jul 22..
Abstract
Excellent liver retransplantation outcomes in hepatitis
C-infected recipients.
Kressel A, Therapondos G,
Bohorquez H, et al
Clin Transplant.
2013 Jul 16
Abstract
Viral status at the time of liver transplantation for
hepatocellular carcinoma: a modern predictor of longterm survival.
Groeschl RT, Hong JC, Christians KK, et al
HPB (Oxford). 2013 Jun 19.
Abstract
Outcome After Liver Transplantation for Cirrhosis Due to Alcohol
and Hepatitis C: Comparison to Alcoholic Cirrhosis and Hepatitis C Cirrhosis.
Singal AK, Hmoud BS, Guturu P,
Kuo YF.
J Clin Gastroenterol.
2013 Jun 6.
Abstract
Imaging of hepatitis C virus infection in liver grafts after
liver transplantation.
Mensa L, Pérez-Del-Pulgar S, et al
J Hepatol. 2013 Mar 30
Abstract |
Long-term
follow-up of endoscopic therapy in stenosis of the bilio-biliary anastomosis
associated with
orthotopic liver
transplantation.
Albert JG, Filmann N, Elsner J,
et al
Liver Transpl.
2013 Mar 22. .
Abstract
Influence of hepatitis C virus infection and high virus serum
load on biliary complications in liver transplantation.
Horster S, Bäuerlein FJ, Mandel P, et
al
Transpl Infect Dis.
2013 Mar 1
Abstract
Antiviral therapy of symptomatic HCV–mixed
cryoglobulinemia after liver transplant: Case
report and
literature review.
Francesca Donato M, Banfi G, et al
Int J Artif Organs.
2013 Feb 28:0..
Abstract
Comparison of results of combined liver-kidney
transplantation vs. isolated liver transplantation.
Aguilera V, Ferrer I,
Berenguer M, et al
Ann Hepatol.
2013 Mar;12(2):274-81
Abstract |
Non-invasive assessment of liver graft fibrosis by
transient elastography after liver transplantation.
Barrault C,
Roudot-Thoraval F, et al
Clin Res Hepatol Gastroenterol.
2013 Jan 10
Abstract
The meaning of tissue and serum HCV RNA
quantitation in hepatitis C recurrence after liver
transplantation: A retrospective study.
Vasuri F, Morelli MC, Gruppioni E,
et al
Dig Liver Dis.
2013 Jan 11
Abstract |
Hepatic Preservation Injury: Severity of Hepatitis C Recurrence
and Survival After Liver Transplantation.
Michaels AJ, Dhanasekaran R, Foley DP,
et al
Dig Dis Sci.
2013 Jan 10.
Abstract |
|A WEEK-IN REVIEW
FEATURED REPORT
Liver transplantation for HCV cirrhosis; cautious optimism after
10 years of experience.
Pacholczyk M, Lągiewska B, Lisik W,
et
al
Ann Transplant. 2012 Dec
31;17(4):5-10..
Abstract
The Tor Vergata weaning of immunosuppression protocols in
stable hepatitis C virus liver transplant patients: the 10-year follow-up.
Manzia TM, Angelico R, Baiocchi L, et al
Transpl Int. 2012 Dec 20.
Abstract
Treatment of genotype-1 hepatitis C recurrence after liver
transplant improves survival in both sustained responders and relapsers.
Ponziani FR, Milani A,
Gasbarrini A, et al
Transpl Int. 2012 Dec 11..
Abstract |
Understanding the switchbacks: The impact of direct
antivirals on the minimization of hepatitis C virus recurrence after
transplantation.
Mutimer D.
Liver Transpl.
2012 Nov;18 Suppl 2:S47-51
Abstract |
The Hepatitis Aggressiveness Score (HAS): A Novel Classification System
for Post-Liver Transplantation
Recurrent Hepatitis C.
Moreira RK, Salomao M, Verna EC,
et al
Am J Surg Pathol.
2012 Oct 10.
Abstract
Donor Diabetes Mellitus Is an Independent Risk Factor for Graft Loss in
HCV Positive but Not HCV Negative
Liver Transplant Recipients.
Wu Y, Ahmed A, Kamal A.
Dig Dis Sci. 2012 Aug 26..
Abstract
The Course of Posttransplant Hepatitis C Infection: Comparative Impact of Donor
and Recipient Source of the Favorable
IL28B Genotype and Other Variables.
Duarte-Rojo A, Veldt BJ, Goldstein DD, et sl
Transplantation. 2012 Jun
29.
Abstract
Racial Differences in Fibrosis Progression After HCV-Related Liver
Transplantation.
Layden JE, Cotler S, Brown KA, et al
Transplantation. 2012 Jun
28..
Abstract
Unexpected Maintenance of Hepatitis C Viral Diversity Following
Liver Transplantation.
Gray RR, Strickland SL, Veras NM,
et al
J
Virol. 2012 May 23.
.
Abstract |
No increased mortality from donor or recipient hepatitis B- and/or
hepatitis C-positive serostatus after
related-donor allogeneic hematopoietic cell transplantation.
Tomblyn M, Chen M, Kukreja M,
et al
Transpl Infect Dis. 2012
May 1.
.
Abstract
Effects of ethnicity and socioeconomic status on survival and
severity of fibrosis in liver transplant
recipients with hepatitis C virus.
Verna EC, Valadao R, Farrand E,
et al
Liver Transpl.
2012 Apr;18(4):461-7
Abstract
Recipient and graft survival are not diminished by
simultaneous liver-kidney transplantation:
An analysis of the UNOS database.
Martin EF, Huang J, Xiang Q,
Liver Transpl.
2012 Mar 29. .
Abstract |
Comparison of two non-contemporaneous HCV-liver transplant
cohorts:
strategies
to improve the efficacy of antiviral therapy.
Berenguer M, Aguilera V, Rubín A, et al
J Hepatol.
2012 Feb 4..
Abstract
A Score Predicting Survival After Liver
Retransplantation for Hepatitis C Virus Cirrhosis.
Andres A, Gerstel E, Combescure C,
et al
Transplantation.
2012 Jan 19.
Abstract |
Cumulative risk of cardiovascular events following orthotopic
liver transplantation.
Albeldawi M, Ashish Aggarwal, Madhwal S,
et al
Liver Transpl. 2011 Dec
5
Abstract
Donor-recipient race mismatch in African-American liver
transplant patients with chronic hepatitis C.
Saxena V, Lai JC, O’Leary JG,
et
al
Liver Transpl.
2011 Dec 5.
Abstract
Eradication of hepatitis C virus genotype 1 after liver
transplantation by interferon therapy before
surgery: Report of three patients with analysis of
interleukin-28 polymorphism, hepatitis C virus
core region and interferon-sensitivity determining region.
Kawaoka T, Aikata H, Miyaki D, et al
Hepatol Res.
2011 Nov;41(11):1126-31.
Abstract |
Hepatic Transplant and HCV: A New Playground
for an Old Virus.
Chinnadurai R, Velazquez V, Grakoui A.
Am J Transplant. 2011 Nov 1.
.
Abstract |
Epidemiology and outcome of hepatitis C
relapse in transplant recipients.
Angelico M.
Transplant Proc.
2011 Jul-Aug;43(6):2457-8.
Abstract
A randomized multicenter study comparing steroid-free and standard
immunosuppression for
liver transplant recipients with chronic hepatitis C.
Klintmalm GB, Davis GL, Teperman L,
et al
Liver Transpl.
2011 Aug 17..
Abstract
Major Challenges Limiting Liver Transplantation in the United States.
Wertheim JA, Petrowsky H, Saab S,
et
al
Am J Transplant.
2011 Jun 14.
Abstract
Hepatitis C virus infected females have a higher risk of advanced fibrosis and
graft loss
after liver transplantation than males.
Lai JC, Verna EC, Brown RS Jr,
et al
Hepatology. 2011 Apr 28.
Abstract
Cardiovascular risk factors after liver transplantation: analysis of related
factors.
Pérez MJ, García DM, Taybi BJ, et al
Transplant Proc. 2011
Apr;43(3):739-41.
Abstract
Survival After Liver Transplantation Using Hepatitis C Virus-Positive Donor
Allografts:
Case-Controlled Analysis of the UNOS Database.
Burr AT, Li Y, Tseng JF, et al
World J Surg.
2011 Mar 8.
Abstract
Outcomes for adult living donor liver transplantation: Comparison of A2ALL and
national experience.
Olthoff KM, Abecassis MM, Emond JC, et al
Liver Transpl.
2011 Feb 25.
Abstract
Liver transplantation for hepatocellular carcinoma:
The impact of human immunodeficiency
virus infection.
Vibert E, Duclos-Vallée JC, Ghigna MR,
et al
Hepatology.
2011 Feb;53(2):475-82. .
Abstract
FULL-TEXT ARTICLE
Liver transplantation for hepatitis C and alcoholic liver
disease.
Carbone M, Neuberger J.
J Transplant.
2010;2010:893893.
Paper |
Outcome of liver transplantation for haemophilia.
Yokoyama S, Bartlett A, Dar FS, et al
HPB (Oxford).
2011 Jan;13(1):40-5
Abstract |
FULL-TEXT ARTICLE
Retransplantation for graft failure in chronic hepatitis C
infection:
A good use of a scarce resource?
Rowe IA, Barber KM, Birch R, et al
World J Gastroenterol.
2010 Oct 28;16(40):5070-6.
Paper |
Nucleometric Study of Anisonucleosis, Diabetes and Oxidative
Damage in Liver Biopsies
of Orthotopic Liver Transplant Recipients with Chronic Hepatitis C
Virus Infection.
Guzman G, Chennuri R,
Voros A, et al
Pathol Oncol Res. 2010 Sep 18
Abstract |
Liver allografts from hepatitis C positive donors can offer good outcomes in
hepatitis C
positive recipients: a US National Transplant Registry analysis.
Northup PG, Argo CK, Nguyen DT,
et al
Transpl Int. 2010 Apr 21
Abstract |
Flexible and individualized treatment to achieve sustained
viral response for recurrent hepatitis C
in liver transplant recipients.
Lee WC, Wu TJ, Chou HS, et al
J Viral Hepat.
2010 Mar 23.
Abstract
|
Anti-thymocytes Globulin for the Treatment of Acute Cellular
Rejection Following
Liver Transplantation.
Schmitt TM, Phillips M, Sawyer RG, et al
Dig Dis Sci.
2010 Mar 18.
Abstract |
The Influence of Induction Therapy on Graft
and Patient Survival in Patients
with and without Hepatitis
C after Liver Transplantation.
Moonka DK, Kim D, Kapke A, et al
Am J Transplant.
2009 Dec 2.
Abstract |
Liver transplant for viral hepatitis and fulminant hepatic failure.
Mukherjee S, Mahmoudi TM, Mukherjee U.
Minerva Gastroenterol Dietol.
2009 Mar;55(1):83-100
Abstract
|
Scarce influence of corticosteroid boluses on long-term viral load and
liver histology in
transplanted patients
with recurrent hepatitis C.
Barcena R, Oton E, Barreales M, et al
Transplant Proc. 2006 Oct;38(8):2502-4.
Abstract
The status of liver transplantation for hepatitis C.
Cameron AM, Busuttil RW.
Expert Opin Biol Ther. 2006
Oct;6(10):993-1002.
Abstract
|
|
|
HCV
Main Page
